Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02338947 · ClinicalTrials.gov registry record · NA
Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients
A NA study of Coronary Artery Disease and Frail Elderly, sponsored by University of Sao Paulo General Hospital.
- Active
- Registry status
- NA
- Development phase
- 440
- Enrollment target
- 7
- Study locations
NCT02338947 is a NA study of Coronary Artery Disease and Frail Elderly that is active but no longer recruiting, run by University of Sao Paulo General Hospital. The registered enrollment target is 440 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (66% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT02338947, a NA study of Coronary Artery Disease and Frail Elderly, is active but no longer recruiting, sponsored by University of Sao Paulo General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 440 participants
- Enrollment target
- 7
- Study locations
Study Summary
Frailty is defined as a geriatric syndrome of impaired resiliency to stressors (such as cardiac surgery) that has been delineated recently in the cardiovascular literature. One of the most controversial areas of cardiac surgery has been whether off-pump coronary artery bypass grafting (OPCAB) surgery is superior to conventional on-pump coronary artery bypass grafting (CABG) surgery. There is an ongoing debate about the benefits and disadvantages of OPCAB surgery and we believe that this remains an important technique for the improvement of coronary surgery. The benefits of CABG surgery in frail patients are still undetermined. The aim of this study is to clarify the potential benefit of OPCAB surgery in pre-frail and frail patients by comparing off-pump versus on-pump CABG in these patients.
Conditions Studied
Interventions
- OTHER Off-pump coronary-artery bypass grafting
- OTHER On-pump coronary-artery bypass grafting
Study Locations (7)
São Paulo
- Beneficência Portuguesa de São Paulo - São Paulo
- Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo - São Paulo
Georgia
- Emory University School of Medicine - Atlanta
Ceará
- Hospital de Messejana - Fortaleza
Minas Gerais
- Hospital das Clínicas Samuel Libânio - Pouso Alegre
Paraíba
- Hospital Alberto Urquiza Wanderley - João Pessoa
Rio de Janeiro
- Instituto Nacional de Cardiologia de Laranjeiras - Rio de Janeiro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02338947
The ClinicalTrials.gov registry entry for NCT02338947 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (66% lower). The listed sponsor is University of Sao Paulo General Hospital, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Off-pump coronary-artery bypass grafting is the first listed.
NCT02338947 reports 7 study locations spanning 6 distinct geographic areas - top geographies include São Paulo, Georgia, Ceará.
Frequently Asked Questions
What is clinical trial NCT02338947 about?
NCT02338947 is a clinical study titled "Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients". Frailty is defined as a geriatric syndrome of impaired resiliency to stressors (such as cardiac surgery) that has been delineated recently in the cardiovascular literature. One of the most controversial areas of cardiac surgery has been whether off-pump coronary artery bypass grafting (OPCAB) surger...
What is the current status of trial NCT02338947?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2019-01-01. Estimated completion is 2025-12-31.
What conditions does trial NCT02338947 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Frail Elderly.
What interventions are being tested in trial NCT02338947?
The interventions under investigation include: Off-pump coronary-artery bypass grafting (OTHER), On-pump coronary-artery bypass grafting (OTHER).
Who is sponsoring clinical trial NCT02338947?
This trial is sponsored by University of Sao Paulo General Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02338947 being conducted?
This trial has 7 study locations across Georgia, Ceará, Minas Gerais, Paraíba, Rio de Janeiro. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.